Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone app and booklet could help kidney transplant patients stick to medications

NCT ID NCT07701057

Disease control Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether a smartphone app called MyTherapy, combined with an illustrated educational booklet, can help kidney transplant recipients take their medications correctly and manage their own care. The app sends medication reminders and lets patients track symptoms, while the booklet explains self-care in simple Arabic. Researchers will measure changes in medication adherence and self-management behaviors in 50 adult patients who have had a kidney transplant.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a digital application-based nursing intervention including the MyTherapy smartphone app and an illustrated educational booklet
What this could lead to
If successful, this approach could offer a simple, low-cost way to help kidney transplant recipients better manage their health and avoid complications.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The intervention relies on smartphone access and literacy, which could limit its use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult kidney transplant recipients (aged 20-65 years). * Patients transplanted between June 2024 and June 2026 who are currently maintained on regular outpatient follow-up. * Patients who have access to a smartphone compatible with the mobile application. Exclusion Criteria: * Patients and family members who are illiterate or unable to use the mobile application effectively due to literacy limitations. * Patients with severe cognitive impairment or psychiatric conditions * Patients with auditory and visual disorders. * Patients with failed graft. * Patients who are lost to follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Kidney transplantation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Kidney transplantation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Assiut University Urology Hospital

    Asyut, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.